First MitraClip™ Procedure Performed Using the All-in-One VersaCross™ Transseptal Solution
Press Release
First MitraClip™ Procedure Performed Using the All-in-One VersaCross™ Transseptal Solution
September 23, 2019
TORONTO, September 23, 2019 – Baylis Medical announced today the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped pigtail wire. The device is designed to achieve left-heart access with controlled precision, while reducing the number of exchanges throughout the procedure by serving as an exchange wire once access is achieved. The puncture wire features Baylis’ signature RF puncture technology, which aims to facilitate smooth and precise transseptal procedures. The VersaCross solution also includes the first shapeable sheath and dilator, further allowing transseptal punctures to occur at the optimal location on the septum.
The VersaCross™ Transseptal Solution is available in Pigtail and J-tip RF wire configurations.